Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study

Chronic lymphocytic leukemia (CLL), the most common leukemia worldwide, is associated with increased COVID-19 mortality. Previous studies suggest only a portion of vaccinated CLL patients develop severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibodies. Whether the elicited anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Haydu, J. Erika, Maron, Jenny S., Redd, Robert A., Gallagher, Kathleen M. E., Fischinger, Stephanie, Barnes, Jeffrey A., Hochberg, Ephraim P., Johnson, P. Connor, Takvorian, R. W., Katsis, Katelin, Portman, Daneal, Ruiters, Jade, Sechio, Sidney, Devlin, Mary, Regan, Connor, Blumenthal, Kimberly G., Banerji, Aleena, Judd, Allen D., Scorsune, Krista J., McGree, Brianne M., Sherburne, Maryanne M., Lynch, Julia M., Weitzman, James I., Lei, Matthew, Kotton, Camille N., Dighe, Anand S., Maus, Marcela V., Alter, Galit, Abramson, Jeremy S., Soumerai, Jacob D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789382/
https://www.ncbi.nlm.nih.gov/pubmed/35073571
http://dx.doi.org/10.1182/bloodadvances.2021006627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789382/
https://www.ncbi.nlm.nih.gov/pubmed/35073571
http://dx.doi.org/10.1182/bloodadvances.2021006627

Ejemplares similares